Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 months.

Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 months.

Item
http://www.wikidata.org/entity/Q43000409
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis CRibavirin monotherapy for chronic hepatitis CRibavirin plus interferon versus interferon for chronic hepatitis CHepatitis C advances in antiviral therapy: what is accepted treatment now?Treatment of chronic hepatitis C: a systematic review.Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.High-dose interferon-alpha2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-alpha monotherapy.Retreatment of chronic hepatitis C in previous non-responders and relapsers.Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.High rate of long-term virological response after a 1-year course of interferon +/- ribavirin in chronic hepatitis C relapsers. Results of a 191 patients randomized trial.Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study.Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study.Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C.High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C.Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment.Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.
P2860

Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 months.

Item
http://www.wikidata.org/entity/Q43000409
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Combined treatment of relapse ...... ribavirin for 6 or 12 months.
@en
Combined treatment of relapse ...... ribavirin for 6 or 12 months.
@nl
type
label
Combined treatment of relapse ...... ribavirin for 6 or 12 months.
@en
Combined treatment of relapse ...... ribavirin for 6 or 12 months.
@nl
prefLabel
Combined treatment of relapse ...... ribavirin for 6 or 12 months.
@en
Combined treatment of relapse ...... ribavirin for 6 or 12 months.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Combined treatment of relapse ...... s ribavirin for 6 or 12 months
@en
P2093
P304
P31
P356
10.1016/S0168-8278(00)80282-2
P433
P478
P50
P577
P698